Vimarsana
Biggest News Aggregation in the World

Frank Lis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Frank Lis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Frank Lis Today - Breaking & Trending Today

eXmoor pharma Closes USD 35M Series A Funding - Vimarsana News

eXmoor pharma Closes USD 35M Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

eXmoor pharma completes USD 35 million Series A to expand cell and gene therapy manufacturing capabilities - Vimarsana News

eXmoor pharma completes USD 35 million Series A to expand cell and gene therapy manufacturing capabilities

EXmoor pharma, the end-to-end cell and gene therapy (CGT) manufacturing partner, today announced the close of a USD 35 million Series A financing round, from new investor Kineticos Ventures and existing investor MVM Partners. The funding will help launch eXmoor’s Cell and Gene Therapy Centre, a 65,000 sq ft GMP ...

Inceptor Bio raises $37m from Series A to advance CAR-T lead programme - Vimarsana News

Inceptor Bio raises $37m from Series A to advance CAR-T lead programme

Biotechnology firm Inceptor Bio has raised $37m from Series A funding round that was led by Kineticos Ventures.

Inceptor Bio Announces $37 Million Series A Financing to Develop Cell Therapies for Difficult-to-Treat Cancers - Vimarsana News

Inceptor Bio Announces $37 Million Series A Financing to Develop Cell Therapies for Difficult-to-Treat Cancers

/PRNewswire/ -- Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced the closing of a $37 million...

Inceptor Bio Launches Next-Generation CAR-T, CAR-M, and NK/NKT Platform Focused on Advancing Cell and Gene Therapies to Cure Difficult-To-Treat Cancers - Vimarsana News

Inceptor Bio Launches Next-Generation CAR-T, CAR-M, and NK/NKT Platform Focused on Advancing Cell and Gene Therapies to Cure Difficult-To-Treat Cancers

/PRNewswire/ -- Inceptor Bio, a Research Triangle Park, North Carolina-based cell and gene therapy biotech, announced today that it is developing multiple...